Skip to content

Clinical trials

Observational Reinfection trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reinfection Phase: Observational Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20071
20121
20131
20151
20182
20202
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Completed5
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital3
National Institute of Allergy and Infectious Diseases (NIAID)2
First Affiliated Hospital of Fujian Medical University1
Goztepe Training and Research Hospital1
Groupe Hospitalier Diaconesses Croix Saint-Simon1
Jiming Zhang1
Kirby Institute1
Magdalena Salcedo1
O & O Alpan LLC1
Peking University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reinfection18
COVID-194
Hepatitis C2
Primary Immunodeficiency Diseases2
Acquired Immunodeficiency Syndrome1
Agammaglobulinemia1
Autoimmune Diseases1
Bronchiolitis Obliterans Syndrome1
Coinfection1
Genetic Diseases, Inborn1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.